Anthropic is launching its own drug discovery programs for rare diseases using Claude superintelligence
The news landed like a thunderclap in a San Francisco conference room on June 30, 2026. Anthropic, the artificial intelligence company behind the cutting-edge Claude model, announced it will launch its own preclinical drug-discovery programs targeting neglected diseases, including rare conditions, while simultaneously unveiling Claude Science, an AI workbench built for researchers and drug-makers.
Read Full Article: https://www.naturalnews.com/2026-07-06-anthropic-launching-drug-discovery-programs-rare-diseases.html
